Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 10Thoracic 9Gastrointestinal 5Plasma cell 3Lymphoid 3Dermatologic 3Other hematologic neoplasm 2Genitourinary 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Gynecologic 1Classical hematology 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Fanconi Anemia 1

Interventions

Cyclophosphamide 24fludarabine phosphate 18Whole-Body Irradiation 17fludarabine 16Mycophenolic Acid 16Tacrolimus 12Peripheral Blood Stem Cell Transplantation 12Busulfan 12Melphalan 11apixaban 10Biopsy 7Rivaroxaban 6Granulocyte Colony-Stimulating Factor 6Specimen Handling 5Filgrastim 5Cyclosporine 5Azacitidine 5thymoglobulin 4X-Rays 4Sirolimus 4Rituximab 4Injections 4Enoxaparin 4Decitabine 4Bone Marrow Transplantation 4Aspirin 4Antilymphocyte Serum 4venetoclax 3pegylated granulocyte colony-stimulating factor 3hetrombopag 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Afatinib × Classical hematology × 1 year × Clear all
NCT06648096 2026-05-27

AFAN

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1/2 Recruiting
25 enrolled
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡